Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 May 2023 – 20 Aug 2026, limited by SBI BSE Sensex Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | SBI BSE Sensex Index Fund | Nifty 50 |
|---|---|---|
| 31 May 2023 | ₹100.00 | ₹100.00 |
| 06 Sep 2023 | ₹105.76 | ₹105.81 |
| 13 Dec 2023 | ₹111.85 | ₹112.91 |
| 20 Mar 2024 | ₹116.00 | ₹117.83 |
| 26 Jun 2024 | ₹127.20 | ₹128.78 |
| 02 Oct 2024 | ₹136.54 | ₹139.18 |
| 09 Jan 2025 | ₹125.89 | ₹126.93 |
| 17 Apr 2025 | ₹127.49 | ₹128.69 |
| 24 Jul 2025 | ₹134.18 | ₹135.22 |
| 30 Oct 2025 | ₹138.05 | ₹139.62 |
| 05 Feb 2026 | ₹136.24 | ₹138.35 |
| 14 May 2026 | ₹123.29 | ₹127.81 |
| 20 Aug 2026 | ₹127.66 | ₹130.74 |
| Metric | SBI · Direct · IDCW NAV ₹12.80 Very High risk ★★☆☆☆ | Category median Index Funds · 271 funds |
|---|---|---|
| -4.62% | +5.06% | |
| +6.99% | +7.78% | |
| — | +8.94% | |
| — | +10.39% | |
| +7.87% | +7.54% | |
| +2.18% | — | |
| +6.76% | +8.12% | |
| — | +12.83% | |
| — | +11.97% | |
| Risk | ||
| 13.13% | 13.54% | |
| 0.04 | 0.16 | |
| 0.05 | 0.22 | |
| -16.09% | -15.77% | |
| Nifty 50 | — | |
| -0.85% | +0.53% | |
| 0.99 | 1.00 | |
| 98.3% | 102.2% | |
| 103.6% | 98.0% | |
| 0.24% | 0.34% | |
| ₹310.47Cr | ₹191.88Cr | |
| 0.20% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 54% | 38% | |
| Viral Chhadva · 0.5y | — | |
| 31 May 2023 | — | |
| 30 | — | |
| 64.3% | — | |
| 0.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.